We are happy to share our first webTV interview during which we have explained ABL Diagnostics activity and the development of our market. Co-founders of ABL Group: Dr Sayada & M. Boulmé talked about the original IPO via a reverse take over and they detailed the future operations to improve the stock’s liquidity.

Feel free to contact us (contact@abldiagnostics.com) if you have questions, especially for non-french speakers.